Galectin Therapeutics Inc. (GALT)

[jmh0602]

How much is the company worth if the Phase 2 results are phenomenal and the FDA approves as a surrogate for registration trials? Would they need a partner if they have the only approved drug for NASH cirrhosis? Every liver doctor would know about GR-MD-02. I went back and reviewed the Phase 1, cohorts 1 & 3 results and believe its a real possibility. We never recovered from the Cohort 2 disaster, which was very similar to the FX debacle, creating a huge opportunity for the big payoff. Would a market cap of 5.5 billion be reasonable? $100/share including warrants and options?